BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 26507848)

  • 1. Mallory-Denk bodies: Correlation with steatosis, severity, zonal distribution, and identification with ubiquitin.
    Kayaçetin S; Başaranoğlu M
    Turk J Gastroenterol; 2015 Nov; 26(6):506-10. PubMed ID: 26507848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The genetic background modulates susceptibility to mouse liver Mallory-Denk body formation and liver injury.
    Hanada S; Strnad P; Brunt EM; Omary MB
    Hepatology; 2008 Sep; 48(3):943-52. PubMed ID: 18697208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ufmylation and FATylation pathways are downregulated in human alcoholic and nonalcoholic steatohepatitis, and mice fed DDC, where Mallory-Denk bodies (MDBs) form.
    Liu H; Li J; Tillman B; French BA; French SW
    Exp Mol Pathol; 2014 Aug; 97(1):81-8. PubMed ID: 24893112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TLR3/4 signaling is mediated via the NFκB-CXCR4/7 pathway in human alcoholic hepatitis and non-alcoholic steatohepatitis which formed Mallory-Denk bodies.
    Liu H; Li J; Tillman B; Morgan TR; French BA; French SW
    Exp Mol Pathol; 2014 Oct; 97(2):234-40. PubMed ID: 24997224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatic histopathology of morbid obesity: concurrence of other forms of chronic liver disease.
    Liew PL; Lee WJ; Lee YC; Wang HH; Wang W; Lin YC
    Obes Surg; 2006 Dec; 16(12):1584-93. PubMed ID: 17217634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mallory-Denk Bodies in chronic hepatitis.
    Basaranoglu M; Turhan N; Sonsuz A; Basaranoglu G
    World J Gastroenterol; 2011 May; 17(17):2172-7. PubMed ID: 21633525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mallory-Denk bodies are associated with outcomes and histologic features in patients with chronic hepatitis C.
    Rakoski MO; Brown MB; Fontana RJ; Bonkovsky HL; Brunt EM; Goodman ZD; Lok AS; Omary MB;
    Clin Gastroenterol Hepatol; 2011 Oct; 9(10):902-909.e1. PubMed ID: 21782771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. From Mallory to Mallory-Denk bodies: what, how and why?
    Zatloukal K; French SW; Stumptner C; Strnad P; Harada M; Toivola DM; Cadrin M; Omary MB
    Exp Cell Res; 2007 Jun; 313(10):2033-49. PubMed ID: 17531973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of Tec kinase signaling pathways in the development of Mallory Denk Bodies in balloon cells in alcoholic hepatitis.
    Afifiyan N; Tillman B; French BA; Sweeny O; Masouminia M; Samadzadeh S; French SW
    Exp Mol Pathol; 2017 Oct; 103(2):191-199. PubMed ID: 28935395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mallory-Denk Body (MDB) formation modulates Ufmylation expression epigenetically in alcoholic hepatitis (AH) and non-alcoholic steatohepatitis (NASH).
    Liu H; Gong M; French BA; Li J; Tillman B; French SW
    Exp Mol Pathol; 2014 Dec; 97(3):477-83. PubMed ID: 25290169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL-8 signaling is up-regulated in alcoholic hepatitis and DDC fed mice with Mallory Denk Bodies (MDBs) present.
    Liu H; French BA; Nelson TJ; Li J; Tillman B; French SW
    Exp Mol Pathol; 2015 Oct; 99(2):320-5. PubMed ID: 26260904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship of steatosis grade and zonal location to histological features of steatohepatitis in adult patients with non-alcoholic fatty liver disease.
    Chalasani N; Wilson L; Kleiner DE; Cummings OW; Brunt EM; Unalp A;
    J Hepatol; 2008 May; 48(5):829-34. PubMed ID: 18321606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Familial non-alcoholic steatohepatitis leading to hepatocellular carcinoma.
    Neuman MG; Cohen LB; Malnick S
    Chem Biol Interact; 2020 May; 323():109054. PubMed ID: 32217109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cross β-sheet conformation of keratin 8 is a specific feature of Mallory-Denk bodies compared with other hepatocyte inclusions.
    Mahajan V; Klingstedt T; Simon R; Nilsson KP; Thueringer A; Kashofer K; Haybaeck J; Denk H; Abuja PM; Zatloukal K
    Gastroenterology; 2011 Sep; 141(3):1080-1090.e1-7. PubMed ID: 21699779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ballooned hepatocytes in steatohepatitis: the value of keratin immunohistochemistry for diagnosis.
    Lackner C; Gogg-Kamerer M; Zatloukal K; Stumptner C; Brunt EM; Denk H
    J Hepatol; 2008 May; 48(5):821-8. PubMed ID: 18329127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-fat diet triggers Mallory-Denk body formation through misfolding and crosslinking of excess keratin 8.
    Kucukoglu O; Guldiken N; Chen Y; Usachov V; El-Heliebi A; Haybaeck J; Denk H; Trautwein C; Strnad P
    Hepatology; 2014 Jul; 60(1):169-78. PubMed ID: 24519272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mallory-Denk bodies and hepatocellular senescence: a causal relationship?
    Denk H; Abuja PM; Zatloukal K
    Virchows Arch; 2024 Apr; 484(4):637-644. PubMed ID: 38289501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Over expression of proteins that alter the intracellular signaling pathways in the cytoplasm of the liver cells forming Mallory-Denk bodies.
    Afifiyan N; Tillman B; French BA; Masouminia M; Samadzadeh S; French SW
    Exp Mol Pathol; 2017 Feb; 102(1):106-114. PubMed ID: 28089901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential findings for CD14-positive hepatic monocytes/macrophages in primary biliary cirrhosis, chronic hepatitis C and nonalcoholic steatohepatitis.
    Leicester KL; Olynyk JK; Brunt EM; Britton RS; Bacon BR
    Liver Int; 2006 Jun; 26(5):559-65. PubMed ID: 16762000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of hepatocyte proliferative activity in chronic hepatitis B and C vs. steatohepatitis as assessed by the monoclonal antibody MIB1-Ki-67.
    El-Bendary M; Elalfy H; Zalata K
    Arab J Gastroenterol; 2011 Sep; 12(3):119-24. PubMed ID: 22055588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.